Who invested in Hera Therapeutics?
Hera Therapeutics's investors include Canaan and Sofinnova Investments.
United States · Series B startup
4 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Hera Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$19Mraised across 4 rounds since 2013, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $8.9M sold, first sale May 2015
No investor was named in the report.
From a historical funding recordSEC filing: $1.7M sold, first sale Dec 2014
No investor was named in the report.
From a historical funding recordSEC filing: $1.1M sold, first sale Jun 2014
No investor was named in the report.
Reported by sec.govSEC filing: $1.1M sold, first sale Feb 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Hera Therapeutics's investors include Canaan and Sofinnova Investments.
Hera Therapeutics has raised $19M across 4 rounds since 2013.
Hera Therapeutics's most recent round was a Series B of $16M in Aug 2015.
Its most recent round, $16M in Aug 2015, is also its largest on record.
Hera Therapeutics's first round on record, in Aug 2015, was backed by Canaan and Sofinnova Investments.
Hera Therapeutics's latest named round is a Series B, in Aug 2015.
Hera Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.